| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8537859 | Pulmonary Pharmacology & Therapeutics | 2018 | 22 Pages |
Abstract
Our results indicates that, in patients with PAH associated with other pathological conditions, adenosine is predominantly a positive inotropic agent; and epoprostenol a potent vasodilator of both pulmonary and systemic vessels, and a strong positive inotropic agent.
Keywords
NYHAPVRIPAHmPAPPCWPPAPRHCAdenosinePulmonary vasodilationEuropean Society of CardiologyNew York Heart Associationstandard deviationEpoprostenolCardiac outputESCIntravenousWorld Health Organizationcardiac indexpulmonary vascular resistance indexPVRPulmonary arterial hypertensionPulmonary artery pressuremean pulmonary artery pressurepulmonary capillary wedge pressureBlood pressurePulmonary vascular resistancehuman immunodeficiency virusHIVPulmonary hypertensionRight heart catheterizationWHOPulmonary circulation
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Rosario Rossi, Francesca Coppi, Fabio Sgura, Daniel Monopoli, Giuseppe Boriani,